Literature DB >> 1819366

Lipid trafficking between high density lipoproteins and Babesia divergens-infected human erythrocytes.

A Valentin1, D Rigomier, E Précigout, B Carcy, A Gorenflot, J Schrével.   

Abstract

A two-fold increase in the amount of phospholipids was observed in Babesia divergens infected human red blood cells. In vitro incubation with [32P]-phosphorus and [3H]-glycerol demonstrated that B divergens has the ability to synthesize the phospholipid backbone. On the other hand, the low incorporation of [14C]acetate indicated the absence of a de novo fatty acid synthesis and suggested the necessity of an exogenous lipid source for the parasite. Several intra-erythrocytic growth cycles of B divergens could be achieved in vitro, using a serum-free medium supplemented only with fractions of human high density lipoproteins (HDL). At an HDL concentration of 0.5 mg/ml (protein concentration) and with a 1% starting parasitaemia, parasite growth was similar to that observed under standard culture conditions with 10% human serum, at least for the first 24 h, a time equivalent to three parasite erythrocytic life-cycles. Lipid transfer from HDL to the intra-erythrocytic parasites was demonstrated by uptake and exchange of fluorescent NBD-phosphatidylcholine (NBD-PC) loaded HDL at different temperatures. Kinetic experiments with [3H]-oleyl-PC-loaded HDL demonstrated a unidirectional transfer of lipids from radiolabelled HDL to the parasite; partial conversion of PC to phosphatidylethanolamine (PE) was also observed. In the semi-defined medium, the HDL fraction appeared to be the major source of lipids for the growth of B divergens in human erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819366     DOI: 10.1016/0248-4900(91)90010-k

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  9 in total

1.  Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp.

Authors:  Eric Richier; Giancarlo A Biagini; Sharon Wein; Frederic Boudou; Patrick G Bray; Steve A Ward; Eric Precigout; Michèle Calas; Jean-François Dubremetz; Henri J Vial
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

Review 2.  Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance.

Authors:  Annetta Zintl; Grace Mulcahy; Helen E Skerrett; Stuart M Taylor; Jeremy S Gray
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

3.  Cellular and humoral immune responses induced in cattle by vaccination with Babesia divergens culture-derived exoantigens correlate with protection.

Authors:  A Valentin; E Precigout; M L'Hostis; B Carcy; A Gorenflot; J Schrevel
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

4.  3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes.

Authors:  P Grellier; A Valentin; V Millerioux; J Schrevel; D Rigomier
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

5.  A 37-kilodalton glycoprotein of Babesia divergens is a major component of a protective fraction containing low-molecular-mass culture-derived exoantigens.

Authors:  B Carcy; E Precigout; A Valentin; A Gorenflot; J Schrevel
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

6.  Morphological and Molecular Descriptors of the Developmental Cycle of Babesia divergens Parasites in Human Erythrocytes.

Authors:  Ingrid Rossouw; Christine Maritz-Olivier; Jandeli Niemand; Riette van Biljon; Annel Smit; Nicholas A Olivier; Lyn-Marie Birkholtz
Journal:  PLoS Negl Trop Dis       Date:  2015-05-08

Review 7.  Babesia divergens: A Drive to Survive.

Authors:  Cheryl A Lobo; Jeny R Cursino-Santos; Manpreet Singh; Marilis Rodriguez
Journal:  Pathogens       Date:  2019-07-02

8.  Identification of serum biomarkers in dogs naturally infected with Babesia canis canis using a proteomic approach.

Authors:  Josipa Kuleš; Vladimir Mrljak; Renata Barić Rafaj; Jelena Selanec; Richard Burchmore; Peter D Eckersall
Journal:  BMC Vet Res       Date:  2014-05-12       Impact factor: 2.741

9.  Four-Dimensional Characterization of the Babesia divergens Asexual Life Cycle, from the Trophozoite to the Multiparasite Stage.

Authors:  José Javier Conesa; Elena Sevilla; María Carmen Terrón; Luis Miguel González; Jeremy Gray; Ana J Pérez-Berná; José L Carrascosa; Eva Pereiro; Francisco Javier Chichón; Daniel Luque; Estrella Montero
Journal:  mSphere       Date:  2020-10-14       Impact factor: 4.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.